Nachrichten zur Eli Lilly & Co. Aktie

Eli Lilly builds $1.5 billion stockpile of weight-loss pill ahead of FDA decision

Eli Lilly had $1.5 billion worth of pre-launch inventory of its experimental oral weight-loss drug, a filing showed on Thursday,…

Eli Lilly vs Novo Nordisk in the Weight Loss Drug Market: Heres What Investors Need to Know.

Both companies are betting on interest in weight loss pills.…

Top Analyst Reports for Eli Lilly, Marriott & Fortinet

Eli Lillys Q4 beat and soaring GLP-1 demand lead top analyst picks, alongside fresh insights on Marriott and Fortinets latest…

3 Reasons to Buy Eli Lilly Stock

The healthcare leader looks increasingly unstoppable.…

Missed Out on Eli Lilly? 2 Healthcare Stocks With Big Catalysts on the Horizon.

Could these two companies be biotech giants in the making?…

Eli Lillys 2025 Surge Sets the Stage for Another Big Year in 2026

LLY posts 45% revenue growth to $65.2B in 2025 as GLP-1 drugs power results, and guides $80-$83B in sales with…

Eli Lilly Is Partnering with Gene-Editing Start-up Seamless Therapeutics. Heres What Investors Need to Know.

Eli Lilly is flying high thanks to its success in the GLP-1 space, but what comes next?…

Die unaufhaltsame Pharma-Macht! Eli Lilly ist nach Übernahme von Orna Therapeutics das Maß aller Dinge!

Während der ewige Rivale Novo Nordisk schwächelt, kennt Eli Lilly (LLY) kein Halten mehr. Getrieben von einem beispiellosen Abnehm-Boom explodieren…

Novo Nordisk vs. Eli Lilly: Whats the Better Long-Term Investment?

These stocks have been going in opposite directions of late, but that doesnt mean that trend will continue.…

Over 60% of Eli Lillys Revenue Comes From Its GLP-1 Drugs. Should Investors Be Worried?

Mounjaro and Zepbound generated a combined $11.7 billion in sales for the company in its most recent quarter.…

Why Eli Lilly Stock Just Popped

Novo Nordisk just did Eli Lilly stock a huge favor.…

Eli Lilly buys Orna, Novo Nordisk sues Hims & Hers, Kyndryl plunges

There are a number of stocks moving on the morning of Monday, Feb. 9, including Eli Lilly (LLY), Novo Nordisk…

Here are 10 things to watch in the stock market Monday

Shares of Eli Lilly and Novo Nordisk jumped in premarket trading after Hims & Hers said that the company will…

Missed Out on Eli Lilly? 2 Healthcare Stocks With Big Catalysts on the Horizon.

Eli Lilly is the leader in the GLP-1 space, but heres another GLP-1 stock and a medical device maker to…

Eli Lilly vs Novo Nordisk: The 1 Figure Investors Shouldnt Ignore

The market for obesity drugs may soon reach almost $100 billion.…

Stocks making the biggest moves premarket: Amazon, Reddit, Strategy, Molina, Strategy, Eli Lilly & more

These are the stocks posting the largest moves in premarket trading.…

Walmart’s $1T valuation: A bet on high-income shoppers

For years, the trillion-dollar club was an exclusive playground for tech giants, with their big spends and even bigger revenues.…

Hims & Hers Launches New Pill That Sends Shockwaves Across Weight-Loss Drugmakers Stocks

Hims & Hers Health, Eli Lilly, and Novo Nordisk shares all slid Thursday after Hims & Hers said it would…

Eli Lilly Just Delivered Fantastic News to Shareholders

The stock price has climbed in the triple digits over three years.…

Hims & Hers offers cheaper weight-loss pill in a shock to Novo

STORY: Shares of Novo Nordisk plunged again on Thursday after online telehealth firm Hims & Hers said it will offer…

This Healthcare Company Believes Its GLP-1 Pill Could Be "Next in Line" After Novo Nordisk and Eli Lilly. Its Valuation Is a Fraction of Theirs.

Structure Therapeutics has a promising GLP-1 drug that is about to enter phase 3 trials.…

Why Eli Lilly Stock Just Dropped

Hims & Hers has a GLP-1 weight loss pill -- and its the cheapest one out there.…

Eli Lilly (LLY) im Pivotal-Point-Check: Pharma-Gigant knackt Billionen-Marke - 43 % Umsatzplus und Mega-Ausblick für 2026 lassen den Rivalen Novo-Nordisk alt aussehen!

Für das 4. Quartal 2025 wurde ein Umsatzsprung von 43 % auf 19,3 Mrd. USD gemeldet.   Die Verkäufe von Mounjaro und Zepbound verdoppeln sich nahezu und treiben…

Die Machtübernahme! Eli Lilly besteigt den Pharma-Thron und lässt Novo Nordisk alt aussehen!

Eli Lilly (LLY) ist nicht mehr nur ein Pharmaunternehmen, es ist eine unaufhaltsame Wachstumsmaschine. Während die Konkurrenz strauchelt, liefert der…

Can Pfizer Crash the Lilly and Novo Nordisk Weight-Loss Party?

Eli Lilly and Novo Nordisk may want to enjoy their duopoly while they can.…

Were raising our price target on Eli Lilly as the GLP-1 leader delivers a huge beat

Combined sales for the companys blockbuster GLP-1 drugs Zepbound and Mounjaro exceeded $1 billion, with each showing triple-digit growth.…

Eli Lillys GLP-1 growth is only getting started as Novo Nordisk braces for a decline in 2026

The split in outlook underscores Lillys strong position in the obesity market, underpinned by more effective drugs and its direct-to-consumer…

Open Interest 2/4/2026

Get a jump start on the US trading day with Matt Miller and Dani Burger on "Bloomberg Open Interest." AI…

Eli Lilly Soared by 39% in 2025, but Heres Another Healthcare Stock to Buy in 2026

Eli Lilly is riding the GLP-1 gravy train, while this competitor is struggling to get on board.…

Eli Lilly (LLY) Q4 2025 Earnings Call Transcript

Image source: The Motley Fool.DateFeb. 4, 2026 at 10 a.m. ETCall participantsChair and Chief Executive Officer — David RicksChief Financial…

Eli Lilly Says Weight Loss Pill On Track for 2Q Launch in US

Eli Lilly Chief Financial Officer Lucas Montarce says their weight loss pill is on track to launch in the US in…

Days after announcing Lehigh Valley investment, Eli Lilly predicting a blockbuster 2026

On Wednesday morning, the pharmaceutical giant with headquarters in Indianapolis, Ind. announced its financial results for the fourth quarter of…

Stocks making the biggest moves premarket: AMD, Uber, Eli Lilly, Super Micro, Chipotle, Enphase and more

These are the stocks posting the largest moves in premarket trading.…

Pharmahersteller Lilly glänzt mit Prognose - Aktie zieht vorbörslich kräftig an

INDIANAPOLIS (dpa-AFX) - Anders als Konkurrent Novo Nordisk rechnet der US-Pharmahersteller Lilly auch in…

Eli Lilly blows past quarterly estimates, posts strong outlook as Zepbound and Mounjaro sales soar

Eli Lillys full-year guidance comes in stark contrast to the outlook of Novo Nordisk, which warned it sees sales and…

Eli Lilly sees 2026 profit above estimates on weight?loss drug demand By Reuters

Eli Lilly sees 2026 profit above estimates on weight?loss drug demand…

Eli Lilly sees 2026 profit above estimates as demand for weight?loss drugs soars

Eli Lilly forecast 2026 profit above Wall Street estimates on Wednesday, betting on surging demand for its obesity drugs as…

Eli Lilly shares soar after Q4 beat, strong forecast on weight-loss drugs

Eli Lilly and Co (NYSE:LLY) shares surged 9.5% in Wednesday morning trading after the drugmaker posted fourth-quarter results that topped…

Citi flags bigger tests ahead after Novo Nordisk diabetes trial success

Bank says latest CagriSema results meet expectations, with investor focus shifting to head-to-head data against Eli Lilly’s tirzepatide. Novo Nordisk...…

Obesity market sales potential tightens as Novo and Lilly enter new era

The long-held Wall Street expectation that the global market for obesity drugs would reach $150 billion in the next decade…

Cramer’s week ahead: Earnings from Eli Lilly, Alphabet and Amazon. Plus, jobs data

AMD, Alphabet and Amazon are among the heavyweight companies reporting earnings in the week ahead.…

Why the Market Dipped But Eli Lilly (LLY) Gained Today

In the closing of the recent trading day, Eli Lilly (LLY) stood at $1, denoting a +1.27% move from the…

Futures: Risk-Off Shift For Market?

Google, AMD, Eli Lilly, Amazon and Palantir headline another big earnings week.…

Eli Lilly CEO says Medicare coverage of obesity drugs could change the game for upcoming pill launch

Lilly CEO Dave Ricks is confident in the ability of the companys pill to compete and is preparing for a…

Eli Lilly looks to sharpen its domestic supply edge by building another U.S. plant

Every weekday, the Investing Club releases the Homestretch; an actionable afternoon update just in time for the last hour of…

Eli Lilly plans $3.5 billion manufacturing plant in Pennsylvania to make next-generation obesity injections

The plant will help make Lillys experimental drug called retatrutide, which has shown the highest weight loss seen to date…

Eli Lilly to build $3.5 billion Pennsylvania plant in US manufacturing push

Eli Lilly announced on Friday that it will build a pharmaceutical manufacturing facility in Pennsylvania, its fourth new site in…

FDA Decision on Eli Lillys Weight Loss Pill Delayed to Q2. Is This Bad News for the Stock?

The target action date for orforglipron is now April 10.…

Should You Buy Eli Lilly Before Feb. 4?

Is there another beat-and-raise in the pharmaceutical giants near future?…

Trump says Eli Lilly to build six US plants

U.S. President Donald Trump said on Thursday that he has spoken to the head of pharmaceutical company Eli Lilly and…